|
Ong CA, Shapiro J, Nason KS, Davison JM, Liu X, Ross-Innes C, O'Donova... |
Three-gene immunohistochemical panel adds to clinical staging algorithms to predict prognosis for patients with esophageal adenocarcinoma |
|
J Clin Oncol. |
|
Henrion M, Frampton M, Scelo G, Purdue M, Ye Y, Broderick P, Ritchie A, Kap... |
Common variation at 2q22.3 (ZEB2) influences the risk of renal cancer |
|
Hum Mol Genet. |
|
Griffiths DS, Li J, Dawson MA, Trotter MW, Cheng YH, Smith AM, Mansfield W,... |
LIF-independent JAK signalling to chromatin in embryonic stem cells uncovered from an adult stem cell disease. |
|
Nat Cell Biol. |
|
Wang Y, Broderick P, Matakidou A, Eisen T, Houlston RS. |
Role of 5p15.33 (TERT-CLPTM1L), 6p21.33 and 15q25.1 (CHRNA5-CHRNA3) variation and lung cancer risk in never-smokers |
|
Carcinogenesis |
|
Forshew T, Murtaza M, Parkinson C, Gale D, Tsui DWY, Kaper F, Dawson S-J, P... |
Non-invasive identification and monitoring of cancer mutations by targeted deep sequencing of plasma DNA |
|
Science Translational Medicine |
|
Yuan Y, Failmezger H, Rueda OM, Ali HR, Graf S, Chin S-F, Schwarz RF, Curti... |
Quantitative image analysis of cellular heterogeneity in breast tumors complements genomic profiling |
|
Science Translational Medicine |
|
Phillips, K. A., Milne, R. L., Rookus, M. A., Daly, M. B., Antoniou, A. C.,... |
Tamoxifen and Risk of Contralateral Breast Cancer for BRCA1 and BRCA2 Mutation Carriers |
|
J Clin Oncol |
|
1.1 Walter FM, Morris HC, Humphrys E, Hall PN, Kinmonth A, Prevost A, Wilso... |
Effect of adding a diagnostic aid to best practice to manage suspicious pigmented lesions in primary care: randomised controlled trial. |
|
BMJ |
|
Patil S, Manola J, Elson P, Negrier S, Escudier B, Eisen T, Atkins M, Bukow... |
Improvement in overall survival of patients with advanced renal cell carcin... |
|
J Urol. |
|
Dvinge H, Git A, Graf S, Salmon-Divon M, Curtis C, Sottoriva A, Zhao Y, Hir... |
The shaping and functional consequences of the miRNA landscape in breast cancer |
|
Nature |
